Table 9.
Medical outcomes by latent class transition patterns of end-of-life treatment congruence longitudinally from Time1 to Time2
| Medical outcome | Latent transition from high to high |
||||
|---|---|---|---|---|---|
| Yes N (%) |
No N (%) |
Difference of Percentage (95% CI) |
Chi-square value | P-valuea | |
| Viral load undetectable (< 50) (N = 151) | 67 (84.8) | 56 (77.8) | 7.0 (−5.4, 19.5) | 1.23 | 0.27 |
| CD4 < 500 (N = 151) | 27 (34.6) | 22 (30.1) | 4.5 (−10.4, 19.4) | 0.35 | 0.56 |
| Co-morbidities (N = 173) | 56 (60.9) | 57 (70.4) | −9.5 (−23.6, 4.6) | 1.72 | 0.19 |
| Latent transition from high to low |
|||||
| Yes N (%) |
No N (%) |
Difference of percentage (95% CI) |
Chi-square value | P-valuea | |
| Viral load undetectable (< 50) (N = 151) | 37 (80.4) | 86 (81.9) | −1.5 (−15.1, 12.2) | 0.05 | 0.83 |
| CD4 < 500 (N = 151) | 13 (28.3) | 36 (34.3) | −6.0 (−21.9, 9.8) | 0.53 | 0.47 |
| Co-morbidities (N = 173) | 35 (68.6) | 78 (63.9) | 4.7 (−10.6, 20.0) | 0.35 | 0.55 |
| Latent transition from low to low |
|||||
| Yes N (%) |
No N (%) |
Difference of percentage (95% CI) |
Chi-square value | P-valuea | |
| Viral load undetectable (< 50) (N = 151) | 17 (70.8) | 106 (83.5) | −12.7 (−31.9, 6.7) | 2.13 | 0.14 |
| CD4 < 500 (N = 151) | 9 (36.0) | 40 (31.8) | 4.2 (−16.2, 24.8) | 0.17 | 0.68 |
| Co-morbidities (N = 173) | 21 (75.0) | 92 (63.5) | 11.5 (−6.3,29.4) | 1.38 | 0.24 |
Pearson chi-square test
Time 1 immediately post-intervention. Time 2 12 months post-intervention. CI confidence interval
a
Latent transition from Low to High Congruence (N = 2) was excluded